Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 18.17 Delayed Data As of Jul 01 |  +0.45 / +2.54%Today’s Change | 14.04 Today|||52-Week Range 25.63 | -2.73% Year-to-Date |
Latest COLL News | Press Releases
No recent news for Collegium Pharmaceutical Inc.
Today’s Trading
| Previous close | 17.72 |
| Today’s open | 18.23 |
| Day’s range | 17.50 - 18.31 |
| Volume | 14,773 |
| Average volume (3 months) | 384,630 |
| Market cap | $619.7M |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +163.28% |
| Earnings growth (this year) | +157.74% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | -10.69% |
| P/E ratio | 17.1 |
| Price/Sales | 2.77 |
| Price/Book | 3.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QTRXQuanterix Corp | +0.61 | +3.77% |
| ---- | ||
| VNDAVanda Pharmaceutical... | +0.28 | +2.57% |
| MIRMMirum Pharmaceutical... | +0.50 | +2.57% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $1.51 |
| Annual revenue (last year) | $276.9M |
| Annual profit (last year) | $71.5M |
| Net profit margin | 25.83% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Stoughton, Massachusetts |
Forecasts
